Crescita Therapeutics (CTX) announce voting results from AGM
Tweet
Share
E-mail
Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF), a growth-oriented, innovation-driven Canadian commercial dermatology company, today announced the voting results from its Annual General and Special Meeting of Shareholders held at its corporate headquarters in Laval, Quebec on June 4, 2025. The detailed results of the votes received by proxy are as follows:
Election of Directors
Director Nominees | NUMBER OF SHARES | PERCENTAGE OF VOTES CAST | ||
FOR | WITHHELD | FOR | WITHHELD | |
Daniel N. Chicoine | 5,432,232 | 301,172 | 94.75% | 5.25% |
Anthony E. Dobranowski | 5,455,219 | 278,185 | 95.15% | 4.85% |
John C. London | 5,427,266 | 306,138 | 94.66% | 5.34% |
Deborah Shannon-Trudeau | 5,463,225 | 270,179 | 95.29% | 4.71% |
Serge Verreault | 5,490,982 | 242,422 | 95.77% | 4.23% |
Reappointment of External Auditors
Outcome | NUMBER OF SHARES | PERCENTAGE OF VOTES CAST | ||
FOR | WITHHELD | FOR | WITHHELD | |
Ernst & Young LLP reappointed | 6,388,758 | 49,767 | 99.23% | 0.77% |
Approval of the Continuation of Crescita’s Shareholder Rights Plan
Outcome | NUMBER OF SHARES | PERCENTAGE OF VOTES CAST | ||
FOR | AGAINST | FOR | AGAINST | |
Shareholder Rights Plan approved | 5,481,368 | 252,036 | 95.60% | 4.40% |
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boeing names Ryan Shedd as new SVP and controller
- Curvature Securities terminates ATM sales pact with Planet Green
- Kimbell Royalty closes $221.2M mineral rights acquisition
Create E-mail Alert Related Categories
Corporate NewsRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
